The trademark GuruMA was filed by UAB "Guruma", a corporation established under the laws of the Republic of Lithuania (the "Applicant"). The application was published for oppositions on March 5, 2023, and received one opposition filed on June 4, 2023 by O2 Worldwide Limited on (a) Likelihood of confusion, (b) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by Stobbs Ireland Limited and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued June 4, 2023
The application was filed in Lithuanian, and Lithuanian was also language of all opposition proceedings (English was selected as the second language).
Goods And Services
The mark was filed in class 35 with following description of goods:
Marketing research
Market analysis and research
Business marketing consultancy
Business management consultancy
Data processing services in the field of healthcare
All the aforesaid in relation to medical services, contract clinical research, pharmacovigilance, medical and drug regulatory affairs consultancy and project management.
The mark was filed in class 41 with following description of goods:
Education and instruction
Seminars
Publication of the results of clinical trials
All the aforesaid in relation to medical services, contract clinical research, pharmacovigilance, medical and drug regulatory affairs consultancy and project management.
The mark was filed in class 42 with following description of goods:
Clinical trials
Biological research, clinical research and medical research
Conducting clinical trials for pharmaceutical products
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Providing information about the results of clinical trials for pharmaceutical products
Analytical laboratory services
Clinical research
Technical data analysis services
Research and development services
Consultancy relating to pharmaceutical research and development
All the aforesaid in relation to medical services, contract clinical research, pharmacovigilance, medical and drug regulatory affairs consultancy and project management.
The mark was filed in class 44 with following description of goods:
Providing medical information
Providing information relating to medical services
Remote monitoring of medical data for medical diagnosis and treatment
All the aforesaid in relation to medical services, contract clinical research, pharmacovigilance, medical and drug regulatory affairs consultancy and project management.